Skip to content

Allen & Overy`s Life Sciences team advises Vision Healthcare on the acquisition of Vitamaze

Related people
Veith Alexander
Dr Alexander Veith

Partner

Munich

View profile →

Mayer Linda
Linda Mayer

Associate

Munich

View profile →

Kasten Roman
Dr Roman Kasten

Counsel

Frankfurt am Main

View profile →

Zhuleku Eda
Eda Zhuleku

Counsel

Munich

View profile →

Press contacts

For media enquiries relating to this topic, please contact:

Harald Klett
Harald Klett

Manager PR & Communications

Frankfurt am Main

View profile →

03 December 2021

Allen & Overy has advised Vision Healthcare, a Belgium-based consumer healthcare company with a large portfolio of self-care brands and over-the-counter products in several European countries, on the share purchase agreement with the shareholder of Vitamaze GmbH for the acquisition of 100 percent of shares in Vitamaze GmbH (Vitamaze).

Vitamaze, established in 2015 and headquartered in Heidelberg, Germany, is a leading European vitamins, minerals & nutritional supplements (“VMS”) provider. The company is predominantly active through Amazon marketplaces and e-pharma channels.

Vision Healthcare’s overall VMS & digital marketing expertise combined with Vitamaze’s Amazon & e-pharma expertise will provide Vitamaze with the optimal conditions to launch its next growth wave while allowing the Vision Healthcare group to benefit from Vitamaze’s know-how. The acquisition is in line with Vision Healthcare’s ambitious strategy to further consolidate its leading health-tech platform for direct-to-consumer VMS and beauty and personal care products in Europe.

Allen & Overy´s extensive life sciences expertise across all sectors ensured a deep understanding of the commercial challenges and the regulatory environment, in particular European food and food supplement regulations. The German based Life Sciences team comprises about 20 specialist lawyers covering the full spectrum of legal topics and operates on a cross-border basis. The international Life Sciences team comprises more than 90 lawyers with a deep understanding and technical knowledge of the entire industry.

The Allen & Overy team which advised on all legal, including regulatory, aspects was led by partner Dr Alexander Veith, associate Linda Mayer (both Corporate/M&A/Life-Science, Munich), counsels Dr Roman Kasten (Corporate, Frankfurt) and Eda Zhuleku (Life-Science/Regulatory, Munich). In addition, the wider team included partners Dr Heike Weber (Tax, Frankfurt), Dr Jens Matthes (IP, Dusseldorf) and counsels Dr Sebastian Schulz (Employment and Benefits) and Peter Wehner (Pensions), as well as senior associates Stefanie Guenther (Life-Science/Public Law, Frankfurt), Catharina Glugla (Data Protection), Anna Kraeling (IP, both Dusseldorf) and associates Sven Bischoff (Tax) and Barbara Angene (Employment and Benefits, both Frankfurt).

Senior Associate Alvaro Sanchez-Bordona (Madrid) advised on Spanish law.